Biomarin Pharmaceutical - Registered Shares P/E Ratio

As of the most recent data, BMRN shows a P/E ratio of 170.17. That is above the Healthcare sector average of 25.9. Scroll down for historical charts and peer comparison views.

The Healthcare sector average P/E ratio is about 25.9. Biomarin Pharmaceutical - Registered Shares is at 170.17, which is higher that average. That is roughly 557.1% above the sector mean. Use the comparison chart on this page to see how BMRN stacks up against individual peers as well.

Investors watch BMRN's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Biomarin Pharmaceutical - Registered Shares's latest reading is 170.17. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this p/e ratio page, Stockcircle has Biomarin Pharmaceutical - Registered Shares's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 170.17) with ownership activity and broader fundamentals.

The Healthcare average P/E ratio is about 25.9, while BMRN is at 170.17. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.